Bilirubin Elevation During Hospitalization Post Radiofrequency Catheter Ablation of Persistent Atrial Fibrillation: Variation Trend, Related Factors, and Relevance to 1-Year Recurrence

References

• Targher G, Byrne CD. Circulating Markers of Liver Function and Cardiovascular Disease Risk. Arterioscler Thromb Vasc Biol. 2015;35:2290–2296. doi:10.1161/ATVBAHA.115.305235
   PubMed Web of Science ®Google Scholar
• Fredenburgh LE, Merz AA, Cheng S. Haeme oxygenase signalling pathway: implications for cardiovascular disease. Eur Heart J. 2015;36:1512–1518. doi:10.1093/eurheartj/ehv114
   PubMed Web of Science ®Google Scholar
• Ayer A, Zarjou A, Agarwal A, Stocker R. Heme Oxygenases in Cardiovascular Health and Disease. Physiol Rev. 2016;96:1449–1508. doi:10.1152/physrev.00003.2016
   PubMed Web of Science ®Google Scholar
• Xu XQ, Lv ZC, Liu QQ, et al. Direct bilirubin: a new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension. Int J Cardiol. 2017;228:895–899. doi:10.1016/j.ijcard.2016.11.036
   PubMed Web of Science ®Google Scholar
• Li XL, Zhao CR, Pan CL, Jiang G, Zhang B. Role of bilirubin in the prognosis of coronary artery disease and its relationship with cardiovascular risk factors: a meta-analysis. BMC Cardiovasc Disord. 2022;22:458. doi:10.1186/s12872-022-02899-w
   PubMed Web of Science ®Google Scholar
• Nilsen DWT, Myhre PL, Solheim S, et al. Total Bilirubin Yields Prognostic Information Following a Myocardial Infarction in the Elderly. Antioxidants. 2023;12. doi:10.3390/antiox12061157
   Web of Science ®Google Scholar
• Yang Y, Wang J, Wai Si Ding A, et al. Serum total bilirubin and long-term prognosis of patients with new-onset non-ST elevation myocardial infarction: a cohort study. BMC Cardiovasc Disord. 2022;22:165. doi:10.1186/s12872-022-02607-8
   PubMedGoogle Scholar
• Calvert P, Lip GYH, Gupta D. Radiofrequency catheter ablation of atrial fibrillation: a review of techniques. Trends Cardiovasc Med. 2023;33:405–415. doi:10.1016/j.tcm.2022.04.002
   PubMed Web of Science ®Google Scholar
• Aktan A, Guzel T, Aslan B, et al. Comparison of the real-life clinical outcomes of warfarin with effective time in therapeutic range and non-vitamin K antagonist oral anticoagulants: insight from the AFTER-2 trial. Kardiol Pol. 2023;81:132–140. doi:10.33963/KP.a2022.0287
   PubMed Web of Science ®Google Scholar
• Khan AR, Khan S, Sheikh MA, Khuder S, Grubb B, Moukarbel GV. Catheter ablation and antiarrhythmic drug therapy as first- or second-line therapy in the management of atrial fibrillation: systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2014;7:853–860. doi:10.1161/CIRCEP.114.001853
   PubMed Web of Science ®Google Scholar
• Shi LZ, Heng R, Liu SM, Leng FY. Effect of catheter ablation versus antiarrhythmic drugs on atrial fibrillation: a meta-analysis of randomized controlled trials. Exp Ther Med. 2015;10:816–822. doi:10.3892/etm.2015.2545
   PubMed Web of Science ®Google Scholar
• Zhu M, Zhou X, Cai H, et al. Catheter ablation versus medical rate control for persistent atrial fibrillation in patients with heart failure: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine. 2016;95:e4377. doi:10.1097/MD.0000000000004377
   PubMed Web of Science ®Google Scholar
• Al Halabi S, Qintar M, Hussein A, et al. Catheter Ablation for Atrial Fibrillation in Heart Failure Patients: a Meta-Analysis of Randomized Controlled Trials. JACC Clin Electrophysiol. 2015;1:200–209. doi:10.1016/j.jacep.2015.02.018
   PubMedGoogle Scholar
• Writing Group M, January CT, Wann LS, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2019;16:e66–e93. doi:10.1016/j.hrthm.2019.01.024
   PubMed Web of Science ®Google Scholar
• Chen X, Bai M, Zhang W, Sun S, Chen X. The incidence, risk factors, and prognosis of postoperative hyperbilirubinemia after cardiac surgery: a systematic review and meta-analysis. Ann Palliat Med. 2021;10:7247–7257. doi:10.21037/apm-21-410
   PubMed Web of Science ®Google Scholar
• Farag M, Veres G, Szabo G, Ruhparwar A, Karck M, Arif R. Hyperbilirubinaemia after cardiac surgery: the point of no return. ESC Heart Fail. 2019;6:694–700. doi:10.1002/ehf2.12447
   PubMed Web of Science ®Google Scholar
• Nishi H, Sakaguchi T, Miyagawa S, et al. Frequency, risk factors and prognosis of postoperative hyperbilirubinemia after heart valve surgery. Cardiology. 2012;122:12–19. doi:10.1159/000338142
   PubMed Web of Science ®Google Scholar
• Liang Q, Zhang Y, Liang J. Elevated Serum Total Bilirubin Might Indicate Poor Coronary Conditions for Unstable Angina Pectoris Patients beyond as a Cardiovascular Protector. Cardiovasc Ther. 2023;2023:5532917. doi:10.1155/2023/5532917
   PubMed Web of Science ®Google Scholar
• Mahabadi AA, Lehmann N, Mohlenkamp S, et al. Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study. Clin Res Cardiol. 2014;103:647–653. doi:10.1007/s00392-014-0697-z
   PubMed Web of Science ®Google Scholar
• Lee SJ, Jee YH, Jung KJ, Hong S, Shin ES, Jee SH. Bilirubin and Stroke Risk Using a Mendelian Randomization Design. Stroke. 2017;48:1154–1160. doi:10.1161/STROKEAHA.116.015083
   PubMed Web of Science ®Google Scholar
• Kundur AR, Santhakumar AB, Bulmer AC, Singh I. Mildly elevated unconjugated bilirubin is associated with reduced platelet activation-related thrombogenesis and inflammation in Gilbert’s syndrome. Platelets. 2017;28:779–785. doi:10.1080/09537104.2017.1280146
   PubMed Web of Science ®Google Scholar
• Tsai MT, Tarng DC. Beyond a Measure of Liver Function-Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients. Int J Mol Sci. 2018;20. doi:10.3390/ijms20010117
   Web of Science ®Google Scholar
• Bulmer AC, Bakrania B, Du Toit EF, et al. Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea. Am J Physiol Heart Circ Physiol. 2018;315:H429–H447. doi:10.1152/ajpheart.00417.2017
   PubMed Web of Science ®Google Scholar
• Yoshida K, Yui Y, Kimata A, et al. Troponin elevation after radiofrequency catheter ablation of atrial fibrillation: relevance to AF substrate, procedural outcomes, and reverse structural remodeling. Heart Rhythm. 2014;11:1336–1342. doi:10.1016/j.hrthm.2014.04.015
   PubMed Web of Science ®Google Scholar
• Madrid AH, Del Rey JM, Rubi J, et al. Biochemical markers and cardiac troponin I release after radiofrequency catheter ablation: approach to size of necrosis. Am Heart J. 1998;136:948–955. doi:10.1016/s0002-8703(98)70148-6
   PubMed Web of Science ®Google Scholar
• Brueckmann M, Wolpert C, Bertsch T, et al. Markers of myocardial damage, tissue healing, and inflammation after radiofrequency catheter ablation of atrial tachyarrhythmias. J Cardiovasc Electrophysiol. 2004;15:686–691. doi:10.1046/j.1540-8167.2004.03371.x
   PubMed Web of Science ®Google Scholar
• Richter B, Gwechenberger M, Socas A, et al. Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol. 2012;101:217–225. doi:10.1007/s00392-011-0383-3
   PubMed Web of Science ®Google Scholar
• Ryter SW. Heme Oxygenase-1: an Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders. Antioxidants. 2022;11. doi:10.3390/antiox11030555
   Web of Science ®Google Scholar
• Nedios S, Tang M, Roser M, et al. Characteristic changes of volume and three-dimensional structure of the left atrium in different forms of atrial fibrillation: predictive value after ablative treatment. J Interv Card Electrophysiol. 2011;32:87–94. doi:10.1007/s10840-011-9591-z
   PubMed Web of Science ®Google Scholar
• Kataoka T, Hamasaki S, Inoue K, et al. Left atrium volume index and pathological features of left atrial appendage as a predictor of failure in postoperative sinus conversion. J Cardiol. 2010;55:274–282. doi:10.1016/j.jjcc.2009.11.007
   PubMed Web of Science ®Google Scholar
• Rubattu S, Forte M, Raffa S. Circulating Leukocytes and Oxidative Stress in Cardiovascular Diseases: a State of the Art. Oxid Med Cell Longev. 2019;2019:2650429. doi:10.1155/2019/2650429
   PubMed Web of Science ®Google Scholar
• Guzel T, Kis M, Senoz O. The correlation between the left atrial volume index and atrial fibrillation development in heart failure with mildly reduced ejection fraction and long-term follow-up results. Acta Cardiol. 2022;77:647–654. doi:10.1080/00015385.2022.2067674
   PubMed Web of Science ®Google Scholar